Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/23669
Title: Validity and acceptability of wearable devices for monitoring step-count and activity minutes among people with multiple sclerosis
Authors: Norris, M
Lavelle, G
Flemming, J
Bradley, J
Harper, J
Johnston, H
Fortune, J
Stennett, A
Kilbride, C
Ryan, J
Keywords: multiple sclerosis;wearable devices;physical activity;validity;acceptability;step-count
Issue Date: 11-Jan-2022
Publisher: Frontiers SA
Citation: Norris, M. et al. (2022) 'Validity and acceptability of wearable devices for monitoring step-count and activity minutes among people with multiple sclerosis', Frontiers in Rehabilitation Sciences, 2, 737384, pp. 1-12. doi: 10.3389/fresc.2021.737384.
Abstract: Multiple wearable devices that purport to measure physical activity are widely available to consumers. While they may support increases in physical activity among people with multiple sclerosis (MS) by providing feedback on their performance, there is little information about the validity and acceptability of these devices. Providing devices that are perceived as inaccurate and difficult to use may have negative consequences for people with MS, rather than supporting participation in physical activity. The aim of this study was, therefore, to assess the validity and acceptability of commercially available devices for monitoring step-count and activity time among people with MS. Nineteen ambulatory adults with MS [mean (SD) age 52.1 (11.9) years] participated in the study. Step-count was assessed using five commercially available devices (Fitbit Alta, Fitbit Zip, Garmin Vivofit 4, Yamax Digi Walker SW200, and Letscom monitor) and an activPAL3μ while completing nine everyday activities. Step-count was also manually counted. Time in light activity, moderate-to-vigorous activity, and total activity were measured during activities using an Actigraph GT3X accelerometer. Of the 19 participants who completed the validity study, fifteen of these people also wore the five commercially available devices for three consecutive days each, and participated in a semi-structured interview regarding their perception of the acceptability of the monitors. Mean percentage error for step-count ranged from 12.1% for the Yamax SW200 to −112.3% for the Letscom. Mean step-count as manually determined differed to mean step-count measured by the Fitbit Alta (p = 0.002), Garmin vivofit 4 (p < 0.001), Letscom (p < 0.001) and the research standard device, the activPAL3μ (p < 0.001). However, 95% limits of agreement were smallest for the activPAL3μ and largest for the Fitbit Alta. Median percentage error for activity minutes was 52.9% for the Letscom and 100% for the Garmin Vivofit 4 and Fitbit Alta compared to minutes in total activity. Three inductive themes were generated from participant accounts: Interaction with device; The way the device looks and feels; Functionality. In conclusion, commercially available devices demonstrated poor criterion validity when measuring step-count and activity time in people with MS. This negatively affected the acceptability of devices, with perceived inaccuracies causing distrust and frustration. Additional considerations when designing devices for people with MS include an appropriately sized and lit display and ease of attaching and charging devices.
Description: Supplementary Material: The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fresc.2021.737384/full#supplementary-material
URI: https://bura.brunel.ac.uk/handle/2438/23669
DOI: https://doi.org/10.3389/fresc.2021.737384
Other Identifiers: ORCiD: Meriel Norris https://orcid.org/0000-0001-7779-5612
ORCiD: Grace Lavelle https://orcid.org/0000-0003-3768-1797.
ORCiD: Jennifer Fortune https://orcid.org/0000-0001-8971-1236
ORCiD: Cherry Kilbride https://orcid.org/0000-0002-2045-1883
ORCiD: Jennifer M. Ryan https://orcid.org/0000-0003-3768-2132
737384
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2022 Lavelle, Norris, Flemming, Harper, Bradley, Johnston, Fortune, Stennett, Kilbride and Ryan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.276.85 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons